Free Trial
NASDAQ:ATRC

AtriCure (ATRC) Stock Price, News & Analysis

AtriCure logo
$36.33 +1.25 (+3.56%)
As of 12:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About AtriCure Stock (NASDAQ:ATRC)

Advanced

Key Stats

Today's Range
$35.10
$36.35
50-Day Range
$34.12
$37.87
52-Week Range
$25.57
$43.11
Volume
81,288 shs
Average Volume
549,216 shs
Market Capitalization
$1.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.89
Consensus Rating
Moderate Buy

Company Overview

AtriCure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

ATRC MarketRank™: 

AtriCure scored higher than 59% of companies evaluated by MarketBeat, and ranked 492nd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AtriCure has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 9 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    AtriCure has a consensus price target of $50.89, representing about 45.3% upside from its current price of $35.03.

  • Amount of Analyst Coverage

    AtriCure has only been the subject of 2 research reports in the past 90 days.

  • Read more about AtriCure's stock forecast and price target.
  • Earnings Growth

    Earnings for AtriCure are expected to grow in the coming year, from ($0.60) to ($0.46) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AtriCure is -45.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AtriCure is -45.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AtriCure has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about AtriCure's valuation and earnings.
  • Percentage of Shares Shorted

    4.14% of the outstanding shares of AtriCure have been sold short.
  • Short Interest Ratio / Days to Cover

    AtriCure has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in AtriCure has recently decreased by 0.96%, indicating that investor sentiment is improving.
  • Dividend Yield

    AtriCure does not currently pay a dividend.

  • Dividend Growth

    AtriCure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.14% of the outstanding shares of AtriCure have been sold short.
  • Short Interest Ratio / Days to Cover

    AtriCure has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in AtriCure has recently decreased by 0.96%, indicating that investor sentiment is improving.
  • News Sentiment

    AtriCure has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for AtriCure this week, compared to 6 articles on an average week.
  • MarketBeat Follows

    3 people have added AtriCure to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AtriCure insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $655,633.00 in company stock.

  • Percentage Held by Insiders

    Only 3.50% of the stock of AtriCure is held by insiders.

  • Percentage Held by Institutions

    99.11% of the stock of AtriCure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AtriCure's insider trading history.
Receive ATRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATRC Stock News Headlines

AtriCure to Announce Third Quarter 2025 Financial Results
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
Stocks With Rising Relative Strength: AtriCure
See More Headlines

ATRC Stock Analysis - Frequently Asked Questions

AtriCure's stock was trading at $30.56 on January 1st, 2025. Since then, ATRC stock has increased by 14.6% and is now trading at $35.03.

AtriCure, Inc. (NASDAQ:ATRC) issued its quarterly earnings data on Tuesday, July, 29th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.13. AtriCure's revenue for the quarter was up 17.1% on a year-over-year basis.
Read the conference call transcript
.

AtriCure subsidiaries include SentreHEART.

Shares of ATRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AtriCure investors own include Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
7/29/2025
Today
10/09/2025
Next Earnings (Confirmed)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ATRC
CIK
1323885
Employees
1,300
Year Founded
2000

Price Target and Rating

High Price Target
$60.00
Low Price Target
$45.00
Potential Upside/Downside
+45.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.70 million
Net Margins
-7.27%
Pretax Margin
-7.05%
Return on Equity
-4.20%
Return on Assets
-3.19%

Debt

Debt-to-Equity Ratio
0.16
Current Ratio
3.94
Quick Ratio
2.83

Sales & Book Value

Annual Sales
$465.31 million
Price / Sales
3.75
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.46 per share
Price / Book
3.71

Miscellaneous

Outstanding Shares
49,700,000
Free Float
47,961,000
Market Cap
$1.74 billion
Optionable
Optionable
Beta
1.59

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ATRC) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners